Wayfair Inc. (NYSE: W) reported a wider loss in the fourth quarter due to higher costs and expenses as well as income tax provision. The bottom line was narrower than analysts’ expectations while the top line exceeded consensus estimates. Following this, the stock inched up over 8% in the premarket session.
Net loss was $143.8 million or $1.59 per share, wider than the previous year’s loss of $72.8 million or $0.83 per share. Adjusted loss per share widened to $1.12 from $0.58 in the year-ago quarter.
Direct Retail net revenue, consisting of sales generated primarily through Wayfair’s sites, grew by 40.6% to $2 billion. The number of active customers in Direct Retail business reached 15.2 million as of December 31, 2018, an increase of 37.9% year-over-year.
LTM net revenue per active customer rose by 5% to $443 as of December 31, 2018. Orders per customer, measured as LTM orders divided by active customers, was 1.85 for the fourth quarter of 2018, compared to 1.77 for the fourth quarter of 2017.
Repeat customers placed 66.4% of total orders in the fourth quarter of 2018, compared to 62.4% in the fourth quarter of 2017. Repeat customers placed 5.8 million orders in the fourth quarter of 2018, up 51.1% from last year. Orders delivered in the fourth quarter of 2018 climbed by 42% to 8.8 million. Average order value was $227, compared to $229 for the fourth quarter of 2017.
In the fourth quarter of 2018, 51.8% of total orders delivered for the company’s Direct Retail business were placed via a mobile device, compared to 47.3% in the fourth quarter of 2017.
Shares of Wayfair ended Thursday’s regular session down 0.60% at $117.28 on the NYSE. The stock has risen over 22% in the past year and over 33% in the past three months.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Infographic: Highlights of DocuSign’s (DOCU) Q1 2024 results
DocuSign, Inc. (NASDAQ: DOCU), a leading provider of electronic signature solutions, Thursday reported first-quarter earnings. It also provided guidance for the second quarter and fiscal 2024. The company's top line
Macy’s (M): A few points to consider if you have an eye on this retailer
Shares of Macy’s, Inc. (NYSE: M) stayed in red on Thursday. The stock has dropped 22% year-to-date and 32% over the past 12 months. The retailer witnessed sales and profit
Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said its scientific co-founder Dr. Jonathan Kurtis received a new patent